Morgan Stanley’s CM Life Sciences II Inc. Unit CMIIU Stock Holding History

Morgan Stanley’s Portfolio CMIIU Stock Details CMIIU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-553,946	Closed	-$7.45M	–	8195
2021 Q2	$7.45M	Buy	553,946 +53,694	+11%	+$715K	﹤0.01%	3344
2021 Q1	$6.4M	Buy	+500,252	New	+$6.28M	﹤0.01%	3146

Morgan Stanley's CMIIU Position: Q3 2021 in Review

Morgan Stanley sold out of CM Life Sciences II Inc. Unit (CMIIU) in Q3 2021, closing a stake of 553,946 shares — an estimated $7.45M sold.

Morgan Stanley first reported a position in CMIIU in Q1 2021 and held it in 2 quarters. The position peaked at $7.45M in Q2 2021. 0 funds tracked by Wall St. Rank hold CMIIU as of Q3 2021.

Morgan Stanley reported no remaining CM Life Sciences II Inc. Unit position as of Q3 2021 after selling out during the quarter.
Morgan Stanley sold 553,946 CM Life Sciences II Inc. Unit shares in Q3 2021, an estimated $7.45M.
Morgan Stanley first reported a position in CM Life Sciences II Inc. Unit in Q1 2021 and held it in 2 quarters.
Morgan Stanley's CM Life Sciences II Inc. Unit position peaked at $7.45M in Q2 2021.
0 funds tracked by Wall St. Rank held CM Life Sciences II Inc. Unit as of Q3 2021.

Based on Morgan Stanley's 13F filing for Q3 2021, filed 15 Nov 2021.